Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment

<p>
Background:
Standard proton-pump inhibitor–based therapy for Helicobacter pylori infection fails in up to one quarter of patients. Sequential therapy may be more efficacious.
</p>
<p>Purpose: To compare sequential therapy with standard triple therapy for H. pylori infection. </p>
<p>Study Selection: Randomized, controlled trials (RCTs) comparing sequential and standard triple therapies in treatment-naive patients with documented H. pylori infection. </p>
<p>Data Extraction: 3 reviewers independently assessed trial eligibility and quality and extracted data on eradication. </p>
<p>Data Synthesis: The crude rates of H. pylori eradication in 10 RCTs involving 2747 patients were 93.4% (95% CI, 91.3% to 95.5%) for sequential therapy (n = 1363) and 76.9% (CI, 71.0% to 82.8%) for standard triple therapy (n = 1384) (relative risk reduction, 71% [CI, 64% to 77%]; absolute risk reduction, 16 percentage points [CI, 14 to 19 percentage points]). The median rates of adherence were 97.4% (range, 90.0% to 98.9%) for sequential therapy and 96.8% (range, 93.0% to 100%) for standard therapy. Sequential therapy appeared superior in prespecified sensitivity (subgroup) analyses stratified by trial quality; smoking status; diagnosis (ulcer disease or nonulcer dyspepsia); resistance to clarithromycin, imidazoles, or both; duration of triple therapy; and method of diagnosis. Both treatments had similar side effect profiles. </p>
<p>Limitations: Only 1 study was double-blinded. Most patients were from Italy. There was clear evidence of publication bias. </p>
<p>Conclusions: Sequential therapy appears superior to standard triple therapy for eradication of H. pylori infection. If RCTs in other countries confirm these findings, 10-day sequential therapy could become a standard treatment for H. pylori infection in treatment-naive patients. <br /><br /></p>
<blockquote dir="rtl" style="margin-left:0px">
<p dir="rtl" align="right"><b><font size="3"><font face="Calibri">Annals of Internal Medicine Volume 148 Issue 12</font></font></b></p></blockquote>
<p></p>